⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage 0a bladder cancer ajcc v8

Every month we try and update this database with for stage 0a bladder cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder CancerNCT06173349
Recurrent Non-M...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
PLZ4-coated pac...
18 Years - University of California, Davis
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerNCT00749892
Recurrent Bladd...
Recurrent Renal...
Recurrent Urete...
Recurrent Ureth...
Stage 0a Bladde...
Stage 0a Renal ...
Stage 0a Ureter...
Stage 0a Urethr...
Stage 0is Bladd...
Stage 0is Renal...
Stage 0is Urete...
Stage 0is Ureth...
Stage II Bladde...
Stage II Renal ...
Stage II Ureter...
Stage II Urethr...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IIIA Blad...
Erlotinib Hydro...
19 Years - M.D. Anderson Cancer Center
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerNCT00749892
Recurrent Bladd...
Recurrent Renal...
Recurrent Urete...
Recurrent Ureth...
Stage 0a Bladde...
Stage 0a Renal ...
Stage 0a Ureter...
Stage 0a Urethr...
Stage 0is Bladd...
Stage 0is Renal...
Stage 0is Urete...
Stage 0is Ureth...
Stage II Bladde...
Stage II Renal ...
Stage II Ureter...
Stage II Urethr...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IIIA Blad...
Erlotinib Hydro...
19 Years - M.D. Anderson Cancer Center
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship StudyNCT06350734
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Stage II Bladde...
Stage IIIA Blad...
Non-Interventio...
18 Years - Mayo Clinic
PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder CancerNCT06173349
Recurrent Non-M...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
PLZ4-coated pac...
18 Years - University of California, Davis
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNCT04501913
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Hepatobiliary N...
Malignant Diges...
Malignant Femal...
Malignant Genit...
Malignant Neopl...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage 0 Colorec...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Stage I Cervica...
Stage I Colorec...
Stage I Ovarian...
Stage I Prostat...
Stage I Renal C...
Stage I Uterine...
Stage IA Cervic...
Stage IA Ovaria...
Stage IA Uterin...
Stage IA1 Cervi...
Stage IA2 Cervi...
Stage IB Cervic...
Stage IB Ovaria...
Stage IB Uterin...
Stage IB1 Cervi...
Stage IB2 Cervi...
Stage IC Ovaria...
Stage II Bladde...
Stage II Cervic...
Stage II Colore...
Stage II Ovaria...
Stage II Prosta...
Stage II Renal ...
Stage II Uterin...
Stage IIA Cervi...
Stage IIA Color...
Stage IIA Ovari...
Stage IIA Prost...
Stage IIA1 Cerv...
Stage IIA2 Cerv...
Stage IIB Cervi...
Stage IIB Color...
Stage IIB Ovari...
Stage IIB Prost...
Stage IIC Color...
Stage IIC Prost...
Stage III Bladd...
Stage III Cervi...
Stage III Color...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Blad...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Blad...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Bladde...
Stage IV Cervic...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Bladd...
Stage IVA Cervi...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVA Uteri...
Stage IVB Bladd...
Stage IVB Cervi...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVB Uteri...
Stage IVC Color...
Patient Monitor...
Questionnaire A...
18 Years - City of Hope Medical Center
Behavioral Dietary Intervention for the Improvement of Bladder Cancer SurvivorshipNCT04548193
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Behavioral Diet...
Behavioral Diet...
Educational Int...
Questionnaire A...
18 Years - Roswell Park Cancer Institute
Behavioral Dietary Intervention for the Improvement of Bladder Cancer SurvivorshipNCT04548193
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Behavioral Diet...
Behavioral Diet...
Educational Int...
Questionnaire A...
18 Years - Roswell Park Cancer Institute
Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder CancerNCT04496219
Bladder Urothel...
Recurrent Bladd...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Superficial Bla...
Acupuncture The...
BCG Solution
Best Practice
Quality-of-Life...
Questionnaire A...
18 Years - Fred Hutchinson Cancer Center
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder CancerNCT04164082
Bladder Urothel...
Invasive Bladde...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Gemcitabine Hyd...
Pembrolizumab
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: